Joel N Buxbaum

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Staphylococcus Aureus

Endoplasmic Reticulum

Drug Administration

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Chemical science

Genetics in medicine : official journal of the American College of Medical Genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer West, Sandeep Satapathy, Carolyn M Sue, Megan A Kelly, Nicholas J Geraghty, Emma-Jayne Proctor, Pietro Sormanni, Christopher M Dobson, Joel N Buxbaum, Marie Ranson, Mark R Wilson
Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation. Science advances 7 (50) (2021)
Xin Jiang, Richard Labaudinière, Joel N Buxbaum, Cecília Monteiro, Marta Novais, Teresa Coelho, Jeffery W Kelly
A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction. Proceedings of the National Academy of Sciences of the United States of America 118 (9) (2021)
Madhu Nagaraj, Zahra Najarzadeh, Jonathan Pansieri, Henrik Biverstål, Greta Šneiderienė, Vytautas Smirnovas, Steve Matthews, Cecilia Emanuelsson, Janne Johansson, Joel N Buxbaum, Ludmilla A Morozova-Roche, Daniel Erik Otzen
Chaperones mainly suppress primary nucleation during formation of functional amyloid required for bacterial biofilm formation. Chemical science 13 (2) (2021)
Joel N Buxbaum, Frederick L Ruberg
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genetics in medicine : official journal of the American College of Medical Genetics 19 (7) (2017)